News Detail

This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Benzinga · 3d ago

Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

DA Davidson analyst Brian Holland upgraded Utz Brands, Inc. (NYSE:UTZ) from Neutral to Buy and maintained the price target of $16. Utz Brands shares closed at $13.39 on Wednesday. See how other analysts view this stock.
JP Morgan analyst Harlan Sur upgraded the rating for Cadence Design Systems, Inc. (NASDAQ:CDNS) from Neutral to Overweight and raised the price target from $300 to $325. Cadence Design Systems shares closed at $265.42 on Wednesday. See how other analysts view this stock.
UBS analyst A.J. Rice upgraded Healthcare Services Group, Inc. (NASDAQ:HCSG) from Neutral to Buy and raised the price target from $12 to $15. Healthcare Services shares closed at $12.19 on Wednesday. See how other analysts view this stock.
Piper Sandler analyst Adam Maeder upgraded the rating for Edwards Lifesciences Corporation (NYSE:EW) from Neutral to Overweight and raised the price target from $73 to $80. Edwards Lifesciences shares closed at $70.46 on Wednesday. See how other analysts view this stock.
Raymond James analyst Michael Rose upgraded Renasant Corporation (NYSE:RNST) from Outperform to Strong Buy and maintained the price target of $40. Renasant shares closed at $31.11 on Wednesday. See how other analysts view this stock.

Considering buying EW stock? Here’s what analysts think:

Read This Next:

Top 2 Consumer Stocks That May Implode This Month

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.